Cryopreserved Osteochondral Allograft
-
Biologics
AlloSource’s ProChondrix CR, Cryopreserved Osteochondral Allograft, To Be Featured At The British Patellofemoral Society Meeting
CENTENNIAL, Colo., Jan. 15, 2021 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products,…
Read More » -
Biologics
Science Behind AlloSource’s Cryopreserved Cartilage Published In Journal Of Orthopaedic Surgery And Research
CENTENNIAL, Colo., Dec. 8, 2020 /PRNewswire/ — AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products…
Read More » -
Biologics
AlloSource Announces First Patient Enrolled In ProChondrix CR Cartilage Defect Study
CENTENNIAL, Colo., March 20, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and tissue,…
Read More » -
Biologics
AlloSource Announces Two-Year Shelf Life On ProChondrix CR Fresh Cryopreserved Osteochondral Allograft
CENTENNIAL, Colo., March 12, 2019 /PRNewswire/ — AlloSource®, an organization dedicated to advancing the science and use of transplantable allogeneic cells and…
Read More »